Epidemiology and etiology of non-Hodgkin lymphoma--a review
- PMID: 16644568
- DOI: 10.1080/02841860500531682
Epidemiology and etiology of non-Hodgkin lymphoma--a review
Abstract
The etiology of non-Hodgkin lymphoma, as well as its global dramatic rise in incidence during the past decades, remains largely unexplained. However, there is increasing awareness that this group of malignancies may entail not only clinical, morphological and molecular heterogeneity, but also considerable variations in terms of etiologic factors. In this review, epidemiologic patterns are summarized as well as current evidence of associations between various known or suspected risk factors for non-Hodgkin lymphoma overall or for any of its subtypes. Central pathogenetic mechanisms include immunosuppression, especially in relation to T-cell function and loss of control of latent EBV infection, and chronic antigen stimulation. Some degree of familiar aggregation also implies a role for genetic susceptibility. A number of recent investigations of non-Hodgkin lymphoma etiology will hopefully lead to a better understanding of the causes of these malignancies.
Similar articles
-
[Epidemiology and etiology of non-Hodgkin's lymphoma].Rev Prat. 2002 May 1;52(9):945-50. Rev Prat. 2002. PMID: 12063759 Review. French.
-
Epidemiology and etiology of non-hodgkin lymphoma.Cancer Treat Res. 2015;165:1-25. doi: 10.1007/978-3-319-13150-4_1. Cancer Treat Res. 2015. PMID: 25655604 Review.
-
Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes.Semin Cancer Biol. 2011 Nov;21(5):293-8. doi: 10.1016/j.semcancer.2011.09.010. Epub 2011 Sep 18. Semin Cancer Biol. 2011. PMID: 21945518 Review.
-
Atopy and risk of non-Hodgkin lymphoma.J Natl Cancer Inst. 2007 Jan 17;99(2):158-66. doi: 10.1093/jnci/djk019. J Natl Cancer Inst. 2007. PMID: 17227999
-
[Unexplained increase of non-Hodgkin lymphoma cases. Immunodeficiency and infections are possible causes].Lakartidningen. 1998 Dec 16;95(51-52):5854-6. Lakartidningen. 1998. PMID: 9889505 Review. Swedish. No abstract available.
Cited by
-
EMAP II Expression Is Increased on Peripheral Blood Cells from Non-Hodgkin Lymphoma.J Immunol Res. 2022 Sep 12;2022:7219207. doi: 10.1155/2022/7219207. eCollection 2022. J Immunol Res. 2022. PMID: 36132984 Free PMC article.
-
Regarding "meta-analysis and causal inference: a case study of benzene and non-Hodgkin lymphoma": an incomplete analysis.Ann Epidemiol. 2011 Jan;21(1):67-9; author reply 70-1. doi: 10.1016/j.annepidem.2010.06.004. Epub 2010 Aug 12. Ann Epidemiol. 2011. PMID: 20705482 Free PMC article. No abstract available.
-
ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex.Mol Cancer. 2014 Jul 29;13:181. doi: 10.1186/1476-4598-13-181. Mol Cancer. 2014. PMID: 25070240 Free PMC article.
-
Unmet need for mental health services in indolent lymphoma: age differences over one-year post-diagnosis.Leuk Lymphoma. 2021 Jun;62(6):1370-1378. doi: 10.1080/10428194.2021.1872071. Leuk Lymphoma. 2021. PMID: 34082646 Free PMC article.
-
Association analysis of genetic variants in the ghrelin and tumor necrosis factor α genes and the risk for non-Hodgkin's lymphoma in Kuwaitis.Cancer Biomark. 2021;32(1):11-18. doi: 10.3233/CBM-200373. Cancer Biomark. 2021. PMID: 34024815 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous